Evaxion Biotech A/S (EVAX)
Evaxion Biotech A/S engages in the discovery and development of immunotherapies for cancer and infectious diseases. Its technologies include the immuno-oncology platform PIONEER, the bacterial disease platform EDEN, the viral disease platform RAVEN, and the proprietary AI platform technology ObsERV. The company was founded by Niels Iversen Møller and Andreas Holm Mattsson on August 11, 2008 and is headquartered in Hoersholm, Denmark.
Address
DR NEERGAARDS VEJ 5F
HOERSHOLM, G7 2970
Founded
2008
Number of Employees
49
Website
http://www.evaxion-biotech.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)